Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Teclistamab-cqyv：首个用于治疗复发或难治性多发性骨髓瘤患者的双特异性T细胞衔接抗体
期刊:
影响因子:
doi:10.6004/jadpro.2023.14.2.7
Hua, Gwen; Scanlan, Ryan; Straining, Rachael; Carlson, Daniel S
T细胞
多发性骨髓瘤
T细胞
骨髓瘤
细胞生物学
免疫/内分泌
